The Antisera market in Spain grew steadily from 2013 to 2019, peaking at 10.089 billion USD, followed by a significant dip in 2020 to 8.4928 billion USD, likely due to the pandemic's impact. The market rebounded by 2021, reaching 10.891 billion USD, but saw a minor decline in 2022. By 2023, it regained stability at 10.644 billion USD. The average annual growth rate over the last five years was approximately 1.37%.

Future trends to watch for include:

Potential impacts of technological advancements in antibody production.
Regulatory changes affecting market dynamics.
Increasing demand for antisera in personalized medicine and biotechnology fields.